Sika Interplant

how big is Sika Interplant?

As of October 2023, Sika Interplant Systems Ltd has a market capitalization of 2,786.22 Cr, with net sales of 147.66 Cr and net profit of 26.53 Cr over the latest four quarters. Shareholder's funds are valued at 103.11 Cr, and total assets amount to 121.74 Cr.

Market Cap: Sika Interplant Systems Ltd has a market capitalization of 2,786.22 Cr, classifying it as a Small Cap company.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 147.66 Cr, and the sum of Net Profit for the latest 4 quarters is 26.53 Cr. This data is Consolidated.<BR><BR>Balance Sheet Snapshot: This is Consolidated data for the latest annual period ending in March 2024. The Shareholder's Funds are valued at 103.11 Cr, and the Total Assets amount to 121.74 Cr.

Who are in the management team of Sika Interplant?

As of March 2022, the management team of Sika Interplant includes Rajeev Sikka (Executive Chairman), Kunal Sikka (Managing Director & CEO), Anuradha Sikka (Director), and Sriee Aneetha M (Company Secretary). The Board also features independent directors C G Krishnadas Nair, R N Chawhan, S Santhanam, and Garimella Bhaskar Venkata Satya.

As of March 2022, the management team of Sika Interplant includes the following individuals:<BR><BR>1. Rajeev Sikka - Executive Chairman & Whole Time Director<BR>2. Kunal Sikka - Managing Director & CEO<BR>3. Anuradha Sikka - Director<BR>4. Sriee Aneetha M - Company Secretary & Compliance Officer<BR><BR>Additionally, the Board of Directors features several independent directors: <BR>- C G Krishnadas Nair<BR>- R N Chawhan<BR>- S Santhanam<BR>- Garimella Bhaskar Venkata Satya<BR><BR>These members contribute to the governance and strategic direction of the company.

What does Sika Interplant do?

Sika Interplant Systems Ltd is an engineering company specializing in the Aerospace, Defence & Space and Automotive sectors, with recent net sales of 46 Cr and a net profit of 8 Cr for the quarter ending March 2025. It has a market cap of Rs 2,826 Cr and key metrics include a P/E of 108.00 and a return on equity of 21.41%.

Overview: <BR>Sika Interplant Systems Ltd is an engineering-driven company focused on the Aerospace, Defence & Space (A&D) and Automotive sectors, categorized as a Small Cap in the Aerospace & Defense industry.<BR><BR>History: <BR>Sika Interplant Systems Ltd was incorporated in 1985 and has been actively involved in its sectors since then. The latest quarterly results reported net sales and net profit for the period ending March 2025.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 46 Cr (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 8 Cr (Quarterly Results - Mar 2025) <BR>Market-cap value: Rs 2,826 Cr (Small Cap)<BR><BR>Key Metrics: <BR>P/E: 108.00 <BR>Industry P/E: 34 <BR>Dividend Yield: 0.15% <BR>Debt-Equity: -0.20 <BR>Return on Equity: 21.41% <BR>Price to Book: 23.10 <BR><BR>Contact Details: <BR>Address: No 3 Gangadhara Chetty Road, Bangalore Karnataka: 560042 <BR>Tel: 91-080-25599144/25599086 <BR>Email: comp.sec@sikaglobal.com <BR>Website: http://www.sikaglobal.com

Has Sika Interplant declared dividend?

Sika Interplant Systems Ltd has declared a 100% dividend, amounting to ₹10 per share, with an ex-date of September 6, 2024. The company has shown impressive total returns, including 3971.6% over the last 5 years.

Sika Interplant Systems Ltd has declared a 100% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 100%<BR>- Amount per share: 10 per share<BR>- Ex-date: 06 Sep 24<BR><BR>Dividend Yield: 0.15%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was 172.96%, with no dividend return, resulting in a total return of 172.96%.<BR><BR>Over the past year, the price return was 180.58%, with a dividend return of 1.86%, leading to a total return of 182.44%.<BR><BR>In the 2-year period, the price return was 1056.22%, accompanied by a dividend return of 11.14%, culminating in a total return of 1067.36%.<BR><BR>For the 3-year period, the price return was 950.54%, with a dividend return of 13.87%, resulting in a total return of 964.41%.<BR><BR>In the 4-year period, the price return was 1806.9%, with a dividend return of 30.05%, leading to a total return of 1836.95%.<BR><BR>Over the last 5 years, the price return was 3896.26%, with a dividend return of 75.34%, resulting in a total return of 3971.6%.<BR><BR>Overall, Sika Interplant has declared a significant dividend while also achieving impressive total returns across multiple periods, indicating strong financial performance and shareholder value enhancement.

Who are the peers of the Sika Interplant?

Sika Interplant's peers include Hind.Aeronautics, Bharat Electron, Mazagon Dock, and others, with varying management risks and growth rates. Mazagon Dock leads in 1-year returns at 111.91%, while Sika Interplant has a return of 80.58%.

Peers: The peers of Sika Interplant are Hind.Aeronautics, Bharat Electron, Mazagon Dock, Bharat Dynamics, Cochin Shipyard, Rossell Techsys, CFF Fluid, Taneja Aerospace, Swan Defence, and Krishna Defence.<BR><BR>Quality Snapshot: Excellent management risk is observed at Hind.Aeronautics, Bharat Electron, and Mazagon Dock, while Good management risk is found at Bharat Dynamics and Cochin Shipyard. Average management risk is present at Sika Interplant, CFF Fluid, Taneja Aerospace, and Krishna Defence, whereas Below Average management risk is noted at Rossell Techsys and Swan Defence. In terms of Growth, Excellent growth is seen at Hind.Aeronautics, Bharat Electron, and CFF Fluid, while Average growth is found at Sika Interplant, and Below Average growth is noted at Bharat Dynamics, Cochin Shipyard, Rossell Techsys, Taneja Aerospace, and Swan Defence. Lastly, Excellent capital structure is observed at Hind.Aeronautics, Bharat Electron, Mazagon Dock, Bharat Dynamics, Cochin Shipyard, and Taneja Aerospace, while Average capital structure is found at CFF Fluid and Krishna Defence, and Below Average capital structure is noted at Rossell Techsys and Swan Defence.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Mazagon Dock at 111.91%, while the peer with the lowest is Rossell Techsys, which has no recorded return. Sika Interplant's 1-year return of 80.58% is lower than that of Mazagon Dock but higher than Rossell Techsys. Additionally, Rossell Techsys, Taneja Aerospace, and Swan Defence have negative six-month returns.

Is Sika Interplant overvalued or undervalued?

As of June 30, 2023, Sika Interplant is considered very expensive and overvalued, with a PE ratio of 104.25 and significant premiums compared to peers, despite a strong year-to-date stock return of 135.13%.

As of 30 June 2023, the valuation grade for Sika Interplant moved from expensive to very expensive, indicating a significant increase in perceived overvaluation. The company is currently considered overvalued based on its high valuation ratios, including a PE ratio of 104.25, an EV to EBITDA ratio of 95.06, and a Price to Book Value of 22.32. These figures suggest that the stock is trading at a premium compared to its earnings and book value.<BR><BR>In comparison to its peers, Sika Interplant's valuation stands out as particularly high, with Rail Vikas at a PE of 69.76 and Tube Investments at 87.5, both of which are also classified as very expensive. Additionally, the company has demonstrated strong returns, with a year-to-date stock return of 135.13% compared to the Sensex's 5.58%, further emphasizing the disparity between its performance and valuation metrics. Overall, Sika Interplant is deemed overvalued in the current market environment.

Who are the top shareholders of the Sika Interplant?

The top shareholders of Sika Interplant are Ultraweld Engineers LLP with 70.1%, followed by Rimo Capital Fund LP at 2.8%. Individual investors hold 21.44%, while two foreign institutional investors collectively own 3.11%, and mutual funds hold no shares.

The top shareholders of Sika Interplant include Ultraweld Engineers LLP, which holds the largest stake at 70.1%. Additionally, Rimo Capital Fund LP is the highest public shareholder with a 2.8% holding. The company also has 21.44% of its shares held by individual investors. There are two foreign institutional investors (FIIs) that collectively hold 3.11%, while mutual funds do not hold any shares in the company.

Is Sika Interplant technically bullish or bearish?

As of October 6, 2025, the trend is mildly bullish due to daily moving averages, but caution is advised as weekly indicators show mild bearishness and monthly RSI indicates potential weakness.

As of 6 October 2025, the technical trend has changed from bullish to mildly bullish. The current stance is mildly bullish, driven primarily by the daily moving averages indicating bullish momentum. However, the weekly MACD and KST are mildly bearish, suggesting some caution in the short term. The monthly MACD remains bullish, providing a stronger long-term outlook. The RSI on the monthly is bearish, indicating potential weakness. Overall, while there are mixed signals, the daily indicators support a mildly bullish perspective.

How has been the historical performance of Sika Interplant?

Sika Interplant has shown significant growth, with net sales increasing from 106.03 crore in March 2024 to 147.66 crore in March 2025, and operating profit rising to 34.84 crore. Total assets and liabilities both reached 151.65 crore, reflecting balanced growth, while cash flow from operating activities decreased to 7.00 crore.

Answer:<BR>The historical performance of Sika Interplant shows significant growth in net sales and profitability over the years, with the latest figures for March 2025 indicating net sales of 147.66 crore, a substantial increase from 106.03 crore in March 2024 and 60.01 crore in March 2023. The total operating income followed a similar upward trend, reaching 147.66 crore in March 2025 compared to 106.03 crore in the previous year. The company's operating profit (PBDIT) also saw a notable rise, climbing to 34.84 crore in March 2025 from 25.27 crore in March 2024. Profit before tax reached 33.08 crore, while profit after tax was recorded at 25.34 crore for the same period. <BR><BR>In terms of expenses, raw material costs increased to 107.58 crore in March 2025, reflecting the growing scale of operations. Total expenditure, excluding depreciation, was 118.84 crore, up from 86.13 crore in March 2024. The company's total assets rose to 151.65 crore, with total liabilities also increasing to 151.65 crore, indicating a balanced growth in both assets and liabilities. Cash flow from operating activities was reported at 7.00 crore, down from 19.00 crore in the previous year, while cash flow from investing activities showed a negative figure of -3.00 crore. Overall, Sika Interplant's financial performance demonstrates a robust growth trajectory, marked by increasing sales, profits, and asset values.<BR><BR>Breakdown:<BR>Sika Interplant's financial metrics reveal a strong growth trajectory, with net sales increasing from 106.03 crore in March 2024 to 147.66 crore in March 2025, and total operating income matching this growth at 147.66 crore. The operating profit (PBDIT) rose to 34.84 crore, while profit before tax reached 33.08 crore, culminating in a profit after tax of 25.34 crore. The company's raw material costs also increased significantly, reflecting the scale of operations, with total expenditure rising to 118.84 crore. On the balance sheet, total assets and total liabilities both stood at 151.65 crore in March 2025, indicating a balanced financial position. Cash flow from operating activities decreased to 7.00 crore, while investing activities showed a cash outflow of -3.00 crore, highlighting the company's investment strategy amidst its growth.

When is the next results date for Sika Interplant Systems Ltd?

The next results date for Sika Interplant Systems Ltd is 11 February 2026.

The next results date for Sika Interplant Systems Ltd is scheduled for 11 February 2026.

Are Sika Interplant Systems Ltd latest results good or bad?

Sika Interplant Systems Ltd's latest results show strong year-on-year growth, with revenue up 55.17% and net profit up 44.43%. However, there are concerns due to a sequential decline in both revenue and profit, indicating potential volatility and execution challenges.

Sika Interplant Systems Ltd's latest results present a mixed picture. On one hand, the company achieved a significant year-on-year growth in both revenue and net profit for Q2 FY26, with revenue increasing by 55.17% to ₹51.58 crores and net profit rising by 44.43% to ₹8.94 crores. This indicates strong underlying demand and operational efficiency, as reflected in an improved operating margin of 20.63%, which is up 243 basis points year-on-year.<BR><BR>However, the results also show a concerning sequential decline, with revenue down 24.16% and net profit down 13.62% compared to the previous quarter. This sharp drop raises questions about order book visibility and execution consistency, which are critical in the project-driven aerospace and defence sector.<BR><BR>Overall, while the year-on-year growth is impressive and suggests a solid long-term trajectory, the quarter-on-quarter declines highlight volatility and potential execution challenges. Investors may need to weigh these factors carefully when assessing the company's performance.

Should I buy, sell or hold Sika Interplant Systems Ltd?

Which are the latest news on Sika Interplant?

Why is Sika Interplant Systems Ltd falling/rising?

As of 13-Mar, Sika Interplant Systems Ltd's stock price is falling, currently at 938.60, reflecting a decrease of 4.21%. The stock is underperforming the market, with significant selling pressure and declining investor interest, attributed to its high valuation despite strong fundamentals.

As of 13-Mar, Sika Interplant Systems Ltd's stock price is falling, currently at 938.60, which reflects a decrease of 41.25 (-4.21%). The stock has been underperforming, having lost 8.03% over the last two days and showing a performance today that underperformed its sector by 4.12%. Additionally, the stock touched an intraday low of Rs 925, indicating significant selling pressure.<BR><BR>The recent decline can be attributed to several factors. Over the past week, the stock has decreased by 3.81%, while the benchmark Sensex has fallen by 5.52%. However, the stock's performance over the last month shows a more pronounced decline of 11.69%, compared to the Sensex's 9.76%. This suggests that while the overall market is experiencing downturns, Sika Interplant Systems Ltd is facing even steeper losses.<BR><BR>Investor participation has also been declining, with delivery volume dropping by 10.63% against the five-day average, indicating reduced interest from investors. Furthermore, the stock is trading below several moving averages, which typically signals bearish sentiment. <BR><BR>Despite the company's strong fundamentals, including a low debt-to-equity ratio and consistent positive results over the last nine quarters, the stock is perceived as having a very expensive valuation with a Price to Book Value of 13.5, which is higher than its peers. This premium valuation, combined with the lack of domestic mutual fund investment, suggests that institutional investors may be hesitant about the stock's current price level.<BR><BR>Overall, the combination of recent price declines, reduced investor participation, and concerns over valuation are contributing to the falling stock price of Sika Interplant Systems Ltd.

Why is Sika Interplant Systems Ltd falling/rising?

As of 14-Mar, Sika Interplant Systems Ltd's stock price is declining, currently at 938.60, down 4.21%. The stock has underperformed its sector and shows reduced investor interest, contributing to its recent price drop.

As of 14-Mar, Sika Interplant Systems Ltd's stock price is falling, currently at 938.60, which represents a decrease of 41.25 or 4.21%. The stock has underperformed its sector by 4.12% today and has been on a consecutive decline for the last two days, resulting in a total drop of 8.03% during this period. Additionally, the stock touched an intraday low of Rs 925, marking a decline of 5.6%.<BR><BR>The recent performance metrics indicate that the stock has experienced a 3.81% decline over the past week and an 11.69% drop over the past month, while year-to-date, it has managed a modest gain of 2.97%. Despite a strong long-term growth trajectory, with net sales growing at an annual rate of 27.62% and operating profit at 33.62%, the stock's current valuation appears expensive, trading at a premium compared to its peers. This is reflected in its high Price to Book Value ratio of 13.5 and a PEG ratio of 1.1, suggesting that the stock may be overvalued relative to its earnings growth.<BR><BR>Furthermore, there has been a noticeable decline in investor participation, with delivery volume falling by 10.63% against the five-day average, indicating reduced interest from investors. The lack of domestic mutual fund investment, with their stake at 0%, may also signal a lack of confidence in the stock's current price level or business outlook. Overall, these factors contribute to the downward pressure on Sika Interplant Systems Ltd's stock price.

Why is Sika Interplant Systems Ltd falling/rising?

As of 15-Mar, Sika Interplant Systems Ltd's stock price is at 938.60, down 4.21%, reflecting underperformance with a 8.03% loss over two days and 3.81% over the week. The stock faces challenges due to high valuation and lack of domestic mutual fund investment, contributing to its downward trend.

As of 15-Mar, Sika Interplant Systems Ltd's stock price is falling, currently at 938.60, reflecting a decrease of 41.25 (-4.21%). The stock has been underperforming, having lost 8.03% over the last two days and is down 3.81% over the past week, while the benchmark Sensex has declined by 5.52% in the same period. <BR><BR>Today's performance indicates that the stock has underperformed its sector by 4.12%. It reached an intraday low of Rs 925, which represents a drop of 5.6%. Additionally, the stock's trading volume has decreased, with delivery volume falling by 10.63% compared to the 5-day average, suggesting a decline in investor participation. <BR><BR>While the company has shown healthy long-term growth with net sales increasing at an annual rate of 27.62% and operating profit at 33.62%, it faces challenges due to its high valuation. The stock's price-to-book value is 13.5, which is considered expensive compared to its peers. Furthermore, despite generating significant returns of 87.72% over the past year, the company's profits have only risen by 48.7%, leading to a PEG ratio of 1.1. <BR><BR>The lack of investment from domestic mutual funds, which hold 0% of the company, may also indicate a lack of confidence in the current valuation or business prospects. Overall, these factors contribute to the stock's current downward trend.